Category Archives: IPR

SCP 30: General statement of Knowledge Ecology International

Source: KEI 26th June, 2019   On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, … Continue reading

Posted in Access to Medecines, IPR, Transparency | Leave a comment

Ingredients for WHO roadmap on access to medicines at civil society side event

Source: Intellectual Property Watch | May 25, 2018 On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the … Continue reading

Posted in Access to Medecines, Cancer, IPR, TRIPS, WHO | Leave a comment

Why the US and pharmaceutical giants want a provision in India’s patent law revoked

Source: Scroll.in | May 02, 2018 India’s patent laws are under attack again. This time, too, the target is a provision not commonly found in patent laws elsewhere. This rule requires patent holders to disclose whether they are working their … Continue reading

Posted in Generics, Indian Patent Law, IPR, Patents | Leave a comment

U.S. wants patent form recall

Source: The Hindu | April 15, 2018 Submission on interpretation of a domestic patent law raises eyebrows The United States Patent and Trademark Office (USPTO) has demanded the elimination of ‘Form 27’— a statutory requirement unique to India’s patent law … Continue reading

Posted in Indian Patent Law, Indian Patent Office, IP Rights, IPR, Patent Enforcement, Patent infringement, US pressure on India | Leave a comment

MSF statement on resumption of EU-India FTA negotiations

Source: MSF Access Campaign | 11 April 2018 Officials from the European Union (EU) and India are expected to meet in Brussels on April 12th to resume technical talks on the long-stalled EU-India free trade agreement (FTA). A leaked draft … Continue reading

Posted in EU-India FTA, IPR, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WTO | Leave a comment

EC publishes report on protection and enforcement of intellectual property rights in “third countries”

Source: Knowledge Ecology International   | March 14, 2018 On March 12, 2018, the European Commission published a report on the “protection and enforcement of intellectual property rights in third countries”. The main objective of the report “is to identify third countries … Continue reading

Posted in IPR, Uncategorized | Leave a comment

The scalpels are out ahead of ‘Special 301’ Report

 by PT Jyothi Datta | The HinduBusinessLine Indian pharma pushes back against US trade body’s criticism of its IPR protection record For the past five years, a lone Indian pharmaceutical representation goes out to the Office of the US Trade … Continue reading

Posted in IPR, Special 301 report, Uncategorized | Leave a comment